Furthermore, our results indicate that KCNJ2 may influence key pathways related to proliferation, migration, invasion, apoptosis, and glucose metabolism in ccRCC cells, thereby contributing to the aggressive phenotype of this cancer. The gene discussed is KCNJ2; the disease is cancer.